The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
The global Atropine market was valued at US$ 501 million in 2023 and is anticipated to reach US$ 443.7 million by 2030, witnessing a CAGR of -1.7% during the forecast period 2024-2030.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
This report aims to provide a comprehensive presentation of the global market for Atropine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine.
Report Scope
The Atropine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atropine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
The global Atropine market was valued at US$ 501 million in 2023 and is anticipated to reach US$ 443.7 million by 2030, witnessing a CAGR of -1.7% during the forecast period 2024-2030.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
This report aims to provide a comprehensive presentation of the global market for Atropine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine.
Report Scope
The Atropine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atropine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Atropine Market Overview
1.1 Product Overview and Scope of Atropine
1.2 Atropine Segment by Type
1.2.1 Global Atropine Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine Segment by Application
1.3.1 Global Atropine Market Value by Application: (2024-2030)
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Global Atropine Market Size Estimates and Forecasts
1.4.1 Global Atropine Revenue 2019-2030
1.4.2 Global Atropine Sales 2019-2030
1.4.3 Global Atropine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atropine Market Competition by Manufacturers
2.1 Global Atropine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atropine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atropine Average Price by Manufacturers (2019-2024)
2.4 Global Atropine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atropine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atropine, Product Type & Application
2.7 Atropine Market Competitive Situation and Trends
2.7.1 Atropine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atropine Players Market Share by Revenue
2.7.3 Global Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atropine Retrospective Market Scenario by Region
3.1 Global Atropine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atropine Global Atropine Sales by Region: 2019-2030
3.2.1 Global Atropine Sales by Region: 2019-2024
3.2.2 Global Atropine Sales by Region: 2025-2030
3.3 Global Atropine Global Atropine Revenue by Region: 2019-2030
3.3.1 Global Atropine Revenue by Region: 2019-2024
3.3.2 Global Atropine Revenue by Region: 2025-2030
3.4 North America Atropine Market Facts & Figures by Country
3.4.1 North America Atropine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atropine Sales by Country (2019-2030)
3.4.3 North America Atropine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atropine Market Facts & Figures by Country
3.5.1 Europe Atropine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atropine Sales by Country (2019-2030)
3.5.3 Europe Atropine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Market Facts & Figures by Country
3.6.1 Asia Pacific Atropine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atropine Sales by Country (2019-2030)
3.6.3 Asia Pacific Atropine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atropine Market Facts & Figures by Country
3.7.1 Latin America Atropine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atropine Sales by Country (2019-2030)
3.7.3 Latin America Atropine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atropine Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atropine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atropine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atropine Sales by Type (2019-2030)
4.1.1 Global Atropine Sales by Type (2019-2024)
4.1.2 Global Atropine Sales by Type (2025-2030)
4.1.3 Global Atropine Sales Market Share by Type (2019-2030)
4.2 Global Atropine Revenue by Type (2019-2030)
4.2.1 Global Atropine Revenue by Type (2019-2024)
4.2.2 Global Atropine Revenue by Type (2025-2030)
4.2.3 Global Atropine Revenue Market Share by Type (2019-2030)
4.3 Global Atropine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atropine Sales by Application (2019-2030)
5.1.1 Global Atropine Sales by Application (2019-2024)
5.1.2 Global Atropine Sales by Application (2025-2030)
5.1.3 Global Atropine Sales Market Share by Application (2019-2030)
5.2 Global Atropine Revenue by Application (2019-2030)
5.2.1 Global Atropine Revenue by Application (2019-2024)
5.2.2 Global Atropine Revenue by Application (2025-2030)
5.2.3 Global Atropine Revenue Market Share by Application (2019-2030)
5.3 Global Atropine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 C²PHARMA
6.1.1 C²PHARMA Corporation Information
6.1.2 C²PHARMA Description and Business Overview
6.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 C²PHARMA Atropine Product Portfolio
6.1.5 C²PHARMA Recent Developments/Updates
6.2 RESONANCE LABORATORIES
6.2.1 RESONANCE LABORATORIES Corporation Information
6.2.2 RESONANCE LABORATORIES Description and Business Overview
6.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
6.2.5 RESONANCE LABORATORIES Recent Developments/Updates
6.3 ROLABO OUTSOURCING
6.3.1 ROLABO OUTSOURCING Corporation Information
6.3.2 ROLABO OUTSOURCING Description and Business Overview
6.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
6.3.5 ROLABO OUTSOURCING Recent Developments/Updates
6.4 Minsheng
6.4.1 Minsheng Corporation Information
6.4.2 Minsheng Description and Business Overview
6.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Minsheng Atropine Product Portfolio
6.4.5 Minsheng Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Corporation Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CR Double-Crane Atropine Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 HENAN PURUI
6.6.1 HENAN PURUI Corporation Information
6.6.2 HENAN PURUI Description and Business Overview
6.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HENAN PURUI Atropine Product Portfolio
6.6.5 HENAN PURUI Recent Developments/Updates
6.7 Albany Molecular Research
6.6.1 Albany Molecular Research Corporation Information
6.6.2 Albany Molecular Research Description and Business Overview
6.6.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Albany Molecular Research Atropine Product Portfolio
6.7.5 Albany Molecular Research Recent Developments/Updates
6.8 Alchem International
6.8.1 Alchem International Corporation Information
6.8.2 Alchem International Description and Business Overview
6.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Alchem International Atropine Product Portfolio
6.8.5 Alchem International Recent Developments/Updates
6.9 SAURAV CHEMICALS
6.9.1 SAURAV CHEMICALS Corporation Information
6.9.2 SAURAV CHEMICALS Description and Business Overview
6.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SAURAV CHEMICALS Atropine Product Portfolio
6.9.5 SAURAV CHEMICALS Recent Developments/Updates
6.10 Katsura Chemical
6.10.1 Katsura Chemical Corporation Information
6.10.2 Katsura Chemical Description and Business Overview
6.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Katsura Chemical Atropine Product Portfolio
6.10.5 Katsura Chemical Recent Developments/Updates
6.11 Hangzhou Vega
6.11.1 Hangzhou Vega Corporation Information
6.11.2 Hangzhou Vega Atropine Description and Business Overview
6.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hangzhou Vega Atropine Product Portfolio
6.11.5 Hangzhou Vega Recent Developments/Updates
6.12 Wuhan senwayer century
6.12.1 Wuhan senwayer century Corporation Information
6.12.2 Wuhan senwayer century Atropine Description and Business Overview
6.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wuhan senwayer century Atropine Product Portfolio
6.12.5 Wuhan senwayer century Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Industry Chain Analysis
7.2 Atropine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Production Mode & Process
7.4 Atropine Sales and Marketing
7.4.1 Atropine Sales Channels
7.4.2 Atropine Distributors
7.5 Atropine Customers
8 Atropine Market Dynamics
8.1 Atropine Industry Trends
8.2 Atropine Market Drivers
8.3 Atropine Market Challenges
8.4 Atropine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
